Detecting breast cancer with a simple blood test using an accessible and low-cost novel real-time platform
Ended Cooperative Agreement Awarded Last action
- Award ID
- R44CA217447
- Recipient
-
Inanovate Inc. UEI K4DLR58DKLH9
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $2,285,406
Award facts
- Assistance listing
- 93.394 Cancer Detection and Diagnosis Research
- Completion date
- Originally
- Place of performance
- North Carolina, USA
Award details come from USAspending.gov.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | -$102 | |
| Amendment | $1 | |
| Amendment | -$1 | |
| Amendment | $989,025 | |
| Amendment | $0 | |
| Amendment | $996,518 | |
| Amendment | $0 | |
| Original award | $299,965 |
Quick answers
Who received award R44CA217447?
R44CA217447 was awarded to Inanovate Inc. by National Cancer Institute (National Institutes of Health) on August 23, 2017.
How much is award R44CA217447 worth?
$2,285,406 has been obligated on R44CA217447.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award